May Ann Coleman, NP
Psychiatric/Mental Health · Martinsville, VANPI 1033661632
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 385 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,667, more than ten times the $229 reported in 2021. Among psychiatric/mental health clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 385 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$868
- AbbVie$698
- Neurocrine Biosciences, Inc.$682
- Lundbeck LLC$536
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$531
- Otsuka America Pharmaceutical, Inc.$463
- plus $3K from 32 others
What the payments were for
- Food & beverage$6,73497%
- Education$2063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 60 | $868 |
| AbbVie | 46 | $698 |
| Neurocrine Biosciences, Inc. | 30 | $682 |
| Lundbeck LLC | 30 | $536 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $531 |
| Otsuka America Pharmaceutical, Inc. | 31 | $463 |
| Johnson & Johnson | 15 | $296 |
| Axsome Therapeutics, Inc. | 13 | $292 |
| Teva Pharmaceuticals USA, Inc. | 17 | $287 |
| Tris Pharma Inc | 10 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $197 |
| Novartis | 10 | $195 |
| Indivior Inc. | 8 | $161 |
| Corium, LLC | 7 | $152 |
| Vanda Pharmaceuticals Inc. | 7 | $151 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $129 |
| Acadia Pharmaceuticals Inc | 7 | $116 |
| AstraZeneca | 6 | $107 |
| Bausch Health US, LLC | 5 | $93 |
| Validus Pharmaceuticals LLC | 1 | $87 |
| E.r. Squibb & Sons, L.L.C. | 3 | $77 |
| Almatica Pharma LLC | 4 | $77 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 3 | $48 |
| Boehringer Ingelheim | 3 | $48 |
| Biogen | 2 | $47 |
| Harmony Biosciences LLC | 2 | $46 |
| Ironshore Pharmaceuticals Inc. | 3 | $45 |
| Pfizer | 3 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Novo Nordisk | 2 | $27 |
| Astellas Pharma US Inc | 1 | $25 |
| Irhythm Technologies, Inc. | 1 | $24 |
| Abbott | 1 | $24 |
| Merck | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$124
How this compares
$6,940 in reported general payments places this provider in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 36 | $300,760 |
| VraylarCariprazine Hcl | 43 | $77,325 |
| SpravatoEsketamine Hcl | 49 | $66,093 |
| Invega SustennaPaliperidone Palmitate | 13 | $44,658 |
| EliquisApixaban | 26 | $30,104 |
| EntrestoSacubitril/Valsartan | 19 | $20,728 |
| TrintellixVortioxetine Hydrobromide | 11 | $12,185 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $2,500 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 38 | $2,250 |
| Clozapine | 18 | $2,117 |
| Duloxetine Hcl | 83 | $1,949 |
| Quetiapine Fumarate | 134 | $1,729 |
| Clonazepam | 90 | $1,067 |
| Aripiprazole | 45 | $997 |
| Olanzapine | 58 | $984 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $682 | $300,76036 claims |
| Johnson & JohnsonSpravato, Invega Sustenna | $296 | $110,75162 claims |
| AbbVieVraylar | $698 | $77,32543 claims |
| PfizerEliquis | $42 | $30,10426 claims |
| NovartisEntresto | $195 | $20,72819 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $197 | $12,18511 claims |
| Almatica Pharma LLCSertraline Hcl | $77 | $60139 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.
Other psychiatric/mental health in Martinsville
- Justin RayChesapeake$127K
- Katia HallChesapeake$88K
- Christine GilmoreBedford$75K
- Sarah FaberNewport News$59K
- Kristine GarciaGlen Allen$46K
- Tonjanika BoydRichmond$40K
- Kirby PatmonRichmond$36K
- Juliana FroschAmherst$36K
- Derick ReedyNickelsville$23K
- Pamela RuppelRoanoke$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.